$MDLZ

7 stories mentioning MDLZ

Every FINWIRES story that references MDLZ, newest first.

Mondelez International Keeps Quarterly Dividend at $0.50 a Share; Payable July 14 to Holders of Record on June 30

Research Alert: CFRA Keeps Hold Opinion On Shares Of Mondelez International

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target price of $63, raised $1, reflects a 19x multiple of projected 2027 EPS, in line with MDLZ's historical forward P/E average. We raise our 2026 EPS estimate by $0.06 to $3.08, but cut 2027's by $0.11 to $3.32. We continue to see headwinds related to chocolate and biscuits divisions, though favorable forex has been helping to a degree. MDLZ highlighted plans to stimulate growth with more promotional activity, which could boost revenues (we see an acceleration in revenues in 2027), but may come with the trade-off of narrower margins. We note that cost-saving efforts can also contribute to staving off some of the margin pressure. MDLZ is largely hedged on its cocoa input costs for 2026 but less so in 2027. Thus, if the substantial rise in cocoa pricing in 2025 does not reemerge, it should help the bottom line in 2027 as cost pressures should ease. Share buybacks have also contributed to EPS, and we note that Q1 2026 share count was down 1.5% from one year earlier.

$MDLZ

Wire47d ago

BofA Securities Raises Price Target on Mondelez International to $67 From $65, Maintains Buy Rating

Mondelez International (MDLZ) has an average rating of overweight and mean price target of $66.92, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $60.80, Change: $+2.25, Percent Change: +3.84%

$MDLZ

Wire47d ago

Mondelez Shows Improving Earnings Visibility, Morgan Stanley Says

Mondelez International (MDLZ) is showing good visibility to continued sequential improvement after delivering a strong Q1 EPS upside, Morgan Stanley said in a report Wednesday.The report said the firm posted "high-quality" EPS beat, with organic sales growth and gross margin exceeding expectations while providing a "conservative" outlook."We see good visibility to continued sequential improvement infundamentals, supported by underlying OSG momentum and the onset of cocoa cost deflation in 2H," the note said.The note said that should drive positive earnings revisions against consensus, while the share valuation remains attractive compared with its multinational peers."At the very least, we view FY26 as increasingly de-risked, whichshould allow the focus to shift more fully to FY27 earnings power, where visibility continues to improve toward a meaningful cocoa-driven margin and EPS inflection," the report said.Morgan Stanley raised its price target to $71 from $70 while reiterating its overweight rating.Price: $61.44, Change: $+2.90, Percent Change: +4.94%

$MDLZ

Research47d ago

Research Alert: Mdlz: A Tough Consumer Environment In Q1

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:MDLZ kicked off 2026 with Q1 adjusted EPS of $0.67, beating consensus by $0.06 but declining 15% in constant currency. Net revenues rose 8.2% to $10.1B with 2.0% organic growth, though adjusted gross margins compressed 270 bps to 30.7% and operating margins narrowed 310 bps to 11.7%. Emerging and developed markets diverged, with emerging markets delivering robust 6.3% organic growth (AMEA +11.3%) while developed markets managed only 0.8% organic growth. MDLZ reiterated 2026 guidance of 0%-2% organic growth and 0%-5% constant currency EPS growth, with free cash flow expected at $3.0B. Cocoa-related headwinds persist in chocolate with continued volume pressure in developed markets, while MDLZ's hedging program limits benefits from recent commodity declines until 2027. Biscuits face ongoing weakness in developed markets, particularly North America. We expect 2026 to be a heavy investment year as MDLZ prioritizes volume stabilization through increased advertising and commercial spending.

$MDLZ

Wire52d ago

Mondelez International Faces Near-Term Headwinds Amid Demand Concerns, RBC Says

Mondelez International (MDLZ) is facing challenges in developed markets and an increasing threat to demand from the Middle East conflict, leading to a more cautious near-term outlook, RBC Capital Markets said Friday in a preview of the company's Q1 results.The company has "relatively high exposure" to the Middle East conflict on both input costs and top line as it sells directly in the region. Mondelez may see potential boycotts of US products in the Middle East region as well as "reduced mobility elsewhere around the world due to energy shortages," the note said.In the US, scanner data is up 1.6% quarter to date, which is about 80 basis points better sequentially, but roughly 60 basis points worse on an underlying two-year average basis.Cookies, the company's largest category with about 45% of US sales, are still seeing volume declines, RBC said, adding that in the US, Mondelez is also facing "significant competitive pressure" from smaller peers, especially in the bars segment.RBC noted it is "modestly below" consensus estimates on the company's top line.Meanwhile, commodity costs remain a challenge, though the company's approach to hedging is more sophisticated than most of its peers, and the worst may be largely behind Mondelez as cocoa prices have declined, the investment firm said.RBC has an outperform rating on Mondelez and a $63 price target.Price: $57.68, Change: $-0.04, Percent Change: -0.06%

$MDLZ

Research62d ago

BTIG Initiates Mondelez International at Buy With $70 Price Target

Mondelez International (MDLZ) has an average rating of overweight and mean price target of $66.12, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$MDLZ